(Press-News.org) San Francisco, September 15, 2014—A prospective study that compared patient-reported outcomes of a broad set of cancer patients with bone metastases demonstrates that single fraction radiation therapy (SFRT) is equally as effective as multiple fraction radiation therapy (MFRT) when pain, function and quality of life are considered, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meeting. The multi-center study indicates that improvements in patients' pain, function and degree of distress were similar between the SFRT and MFRT patients, including for the type of patients who were excluded from previous clinical trials, thus confirming the validity of prior randomized control trials to real-world practice.
All six centers at The BC Cancer Agency in British Columbia, Canada, participated in the study from May to December 2013. A total of 648 patients with bone metastases were evaluated (updated data), including 226 (35 percent) with metastases complicated by fracture or neurological compromise such as spinal cord compression. The mean patient age at diagnosis was 65 years, and 54 percent of the patients were male. Patients received SFRT or MFRT at the discretion of the treating oncologist, with 56 percent (363) receiving SFRT; and 44 percent (285) receiving MFRT. The three most common primary bone metastases sites were genitourinary (31 percent), lung (22 percent) and breast (22 percent), with the spine being the most common site treated (44 percent).
Patients completed both the pre- and post-radiation therapy (RT) questionnaires. The three-question assessments were standardized and designed to measure patients' perception of pain, function and quality of life using a non-dichotomous, ordinal, five-point scale. Patients were asked to rate, on a 0 to 4-point scale (with zero being "not at all" and four being "very much,") the degree of their bone pain; the degree to which the pain interfered with their ability to care for themselves; and their level of frustration with their bone pain.
A multivariable regression analysis of the patient surveys pre- and post-treatment was performed. Comparisons were made between patients who received SFRT versus MFRT. Whether treated with SFRT or MFRT, patients in the broad clinical practice setting (i.e. not a clinical trial) reported similar pain, function and quality of life. There were no significant differences in changes in mean patient-reported outcome scores for SFRT patients versus MFRT patients—pain: 1.29 vs. 1.17 point improvement, respectively (p=0.24); function: 0.80 vs. 0.95 point improvement, (p=0.17); or degree of symptom distress: 1.26 vs. 1.26 point improvement, (p=0.98). Furthermore, the proportion of patients with a partial pain response was similar for patients who receive SFRT versus MFRT (73% versus 73%; p = 0.93) as well as the proportion with a complete pain response (19% versus 22%; p = 0.31).
"Previous research has shown that SFRT is equally effective as more costly and inconvenient MFRT courses for patients with painful bone metastases, however, these studies have been generally limited to well-controlled clinical trials, where many patients are excluded, such as those with poor performance status, fractures or neurological damage," said lead study author Robert A. Olson, MD, MSc, the research and clinical trials lead and a radiation oncologist at the BC Cancer Agency Centre for the North. "There is a very low utilization of SFRT for bone metastases worldwide, partially because oncologists are often reluctant to use SFRT for patients who do not meet the criteria of previous clinical trials. We wanted to determine if SFRT is equally effective as MFRT in the broad clinical practice setting, capturing all types of patients who receive RT for bone metastases. This study is ongoing, and to date, we have collected data from 648 patients who completed questions prior to and after RT. The results support the generalizability of prior randomized controlled trials to real-world practice, thus confirming that SFRT should be the standard management policy for patients with uncomplicated bone metastases. Further research is needed to confirm whether SFRT is also appropriate for complicated bone metastases, though our early results with a modest sample size suggest SFRT may be appropriate in some circumstances. We are hopeful that this will lead to increased use of SFRT for bone metastases throughout the world and improved quality of life for these patients."
The abstract, "Patient Reported Outcomes on the Impact of Single versus Multiple Fraction Palliative Radiotherapy for Uncomplicated Bone Metastases on Pain, Function and Degree of Symptom Distress," will be presented in detail during a scientific session at ASTRO's 56th Annual Meeting at 2:45 p.m. Pacific time on Tuesday, September 16, 2014. To speak with Dr. Olson, please call Michelle Kirkwood on September 14 – 17, 2014, in the ASTRO Press Office at the Moscone Center in San Francisco at 415-978-3503 or 415-978-3504, or email michellek@astro.org.
ASTRO's 56th Annual Meeting, to be held at the Moscone Center in San Francisco, September 14-17, 2014, is the nation's premier scientific meeting in radiation oncology. The 2014 Annual Meeting is expected to attract more than 11,000 attendees including oncologists from all disciplines, medical physicists, dosimetrists, radiation therapists, radiation oncology nurses and nurse practitioners, biologists, physician assistants, practice administrators, industry representatives and other health care professionals from around the world. Led by ASTRO President Bruce G. Haffty, MD, FASTRO, a radiation oncologist specializing in breast cancer, the theme of the 2014 Meeting is "Targeting Cancer: Technology and Biology," and the Presidential Symposium, "Local-regional Management of Breast Cancer: A Changing Paradigm," will feature Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO, to highlight recent practice-changing, landmark studies and current developments in the local-regional management of breast cancer. ASTRO's four-day scientific meeting includes presentation of up to four plenary papers, 360 oral presentations, 1,862 posters and 144 digital posters in more than 50 educational sessions and scientific panels for 20 disease-site tracks. Three keynote speakers will address a range of topics including oncologic imaging, biology and targeting in oncology, and human error and safety concerns: Hedvig Hricak, MD, PhD, Chair of the Department of Radiology and the Carroll and Milton Petrie Chair at Memorial Sloan Kettering Cancer Center; Frank McCormick, PhD, FRS, DSc (hon), Professor Emeritus and the David A. Wood Distinguished Professor of Tumor Biology and Cancer Research of the University of California at San Francisco Helen Diller Family Comprehensive Cancer Center; and Sidney Dekker, PhD, MA, MSc, Professor and Director of the Safety Science Innovation Lab at Griffith University, Brisbane, Australia.
INFORMATION:
ABOUT ASTRO
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals that specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes two medical journals, International Journal of Radiation Oncology, Biology, Physics and Practical Radiation Oncology; developed and maintains an extensive patient website, http://www.rtanswers.org; and created the Radiation Oncology Institute, a non-profit foundation to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. To learn more about ASTRO, visit http://www.astro.org.
2014 American Society for Radiation Oncology (ASTRO) 56th Annual Meeting
News Briefing, Monday, September 15, 2014, 11:00 a.m. Pacific time
Scientific Session: Tuesday, September 16, 2014, 2:45 – 4:15 p.m. PT, the Moscone Center
172 Patient Reported Outcomes on the Impact of Single versus Multiple Fraction Palliative Radiotherapy for Uncomplicated Bone Metastases on Pain, Function and Degree of Symptom Distress
Author Block: J. Conway1, I. Olivotto1, S. Miller2, R. Halperin3, D. Hoegler3, W. Beckham4, J. Stephen5, H. Daudt4, J. French1, R. Olson2, 1Vancouver Cancer Centre, Vancouver, BC, Canada, 2Centre for the North, Prince George, BC, Canada, 3Centre for the Southern Interior, Kelowna, BC, Canada, 4Vancouver Island Cancer Centre, Victoria, BC, Canada, 5Fraser Valley Cancer Centre, Surrey, BC, Canada
Purpose/Objective(s): To compare patient reported outcomes (PROs) following single fraction (SF) as compared with multiple fraction (MF) radiation therapy (RT) for uncomplicated bone metastases in a population-based cohort.
Materials/Methods: Six centres at our institution participated in the Prospective Outcomes and Support Initiative (POSI), to record PROs prior to and 3 weeks following RT for uncomplicated bone metastases. Patients treated between May and December 2013 who provided PROs before and after RT were identified. PROs were standardized and designed to assess patients' perception of pain, function and symptom distress using a non-dichotomous, ordinal, 5-point scale. Comparisons were made between patients who received SF versus MF RT. SFRT versus MFRT was at the discretion of the treating oncologist. A multivariate logistic regression analysis was performed.
Results: 284 patients completed both pre and post-RT assessments. The mean age at diagnosis was 64 years, 50% were male, and 59% received SFRT. The three most common primary sites were genitourinary (29%), lung (24%) and breast (20%). Spine (47%) was the most common site treated. There were no significant differences in changes in mean PRO scores for pain (1.17 vs. 1.02 point improvement; p=0.74), function (0.74 vs. 0.82 point improvement; p=0.61) or degree of symptom distress (1.22 vs. 1.21 point improvement; p=0.94) between patients who received SFRT versus MFRT. Likewise, the proportion of patients with at least a 1-point improvement in pain (68.2% vs. 70.0%; p=0.78), function (73.2% vs. 66.7%; p=0.41), and distress (78.5% vs. 80.7%; p=0.74) were similar between SFRT and MFRT. After controlling for age at diagnosis, gender, fractionation, site of delivery, and disease site there was no significant difference in probability of having an improvement in at least one category between SFRT and MFRT (Odds Ratio=1.43; 95% CI 0.76-2.68; p=0.27).
Conclusions: Improvements in patients' pain, function and degree of distress were similar whether treated with SFRT or MFRT. These population-based data support the generalizability of the randomized controlled trials to real-world practice and confirm that SFRT should be the standard management policy for patients with uncomplicated bone metastases.
Author Disclosure Block: J. Conway: None. I. Olivotto: None. S. Miller: None. R. Halperin: None. D. Hoegler: None. W. Beckham: None. J. Stephen: None. H. Daudt: None. J. French: None. R. Olson: None.
Single fraction RT as effective as multiple fraction RT for bone metastases
According to patient-reported data
2014-09-16
ELSE PRESS RELEASES FROM THIS DATE:
Microbiome research shows each tree species has a unique bacterial identity
2014-09-16
EUGENE, Ore. -- Each tree species has its own bacterial identity. That's the conclusion of University of Oregon researchers and colleagues from other institutions who studied the genetic fingerprints of bacteria on 57 species of trees growing on a Panamanian island.
"This study demonstrates for the first time that host plants from different plant families and with different ecological strategies possess very different microbial communities on their leaves," said lead author Steven W. Kembel, a former postdoctoral researcher in the UO's Institute of Ecology and Evolution ...
Molecular mechanisms of the suppression of axon regeneration by KLF transcription factors
2014-09-16
Molecular mechanisms of the Krüppel-like family of transcription factors (KLFs) have been studied more in proliferating cells than in post-mitotic cells such as neurons. Prof. Jeffrey L. Goldberg who comes from University of California San Diego, USA and his team recently found that KLFs regulate intrinsic axon growth ability in central nervous system (CNS) neurons including retinal ganglion cells, and hippocampal and cortical neurons. With at least 15 of 17 KLF family members expressed in neurons and at least 5 structurally unique subfamilies, it is important to ...
Give progesterone a chance
2014-09-16
There is currently no standard pharmacological treatment for spinal cord injury. Here, Dr. Florencia Labombarda, who comes from Buenos Aires University, Argentina suggests that progesterone, a steroid hormone, may be a promising therapeutical candidate as it is already for traumatic brain injury, where it has reached phase II clinical trials. We rely on previous works showing anti-inflammatory, neuroprotective and promyelinating roles for progesterone after spinal cord injury and in our recent paper, in which we demonstrate that progesterone diminishes lesion, preserves ...
The role of DJ-1 in the oxidative stress cell death cascade after stroke
2014-09-16
Oxidative stress is closely associated with secondary cell death in many disorders of the central nervous system including stroke, Parkinson's disease, Alzheimer's disease. Among many aberrant oxidative stress-associated proteins, DJ-1 has been associated with the oxidative stress cell death cascade primarily in Parkinson's disease. Although principally expressed in the cytoplasm and nucleus, DJ-1 can be secreted into the serum under pathological condition. Recently, a close pathological association between DJ-1 and oxidative stress in stroke has been implicated. To this ...
A heart-felt need for dairy food
2014-09-16
A daily small serve of dairy food may reduce the risk of heart disease or stroke, even in communities where such foods have not traditionally formed part of the diet.
A study of nearly 4000 Taiwanese, led by Emeritus Professor Mark Wahlqvist from Monash University's Department of Epidemiology and Preventive Medicine and the Monash Asia Institute, considered the role increased consumption of dairy foods had played in the country's gains in health and longevity.
"In a dominantly Chinese food culture, unaccustomed to dairy foods, consuming them up to seven times a ...
More cheese, please! News study shows dairy is good for your metabolic health
2014-09-16
This news release is available in French. Dairy is considered part of a healthy diet and dietary guidelines recommend the daily consumption of 2-4 portions of milk-based products such as milk, yogurt, cheese, cream and butter.
It's well known that dairy products contain calcium and minerals good for bones, but new research has shown that dairy consumption may also have beneficial effects on metabolic health and can reduce risk of metabolic diseases such as obesity and type 2 diabetes.
Curious about these impacts, researchers from CHU de Québec Research Center ...
Judging a fish by its color: for female bluefin killifish, love is a yellow mate
2014-09-16
VIDEO:
NYU Polytechnic School of Engineering researchers and their collaborators at University of Illinois at Urbana-Champaign found that fertile killifish females preferred swimming near a male replica that moved through the...
Click here for more information.
There's an old adage that warns against passing judgment based on appearance, but female bluefin killifish, like many animal species, apparently don't share such human wisdom when choosing a mate. Researchers at the New ...
Unraveling cell division
2014-09-16
This news release is available in Spanish. CRG researchers shed new light on mitosis. The study published in the Journal of Cell Biology describes how Topo 2 disentangles DNA molecules and is essential for proper cell division
At this very moment thousands of our body's cells are duplicating and dividing. This is the mechanism by which the body repairs damaged tissues and regenerates others like skin and hair. It involves a fairly complex process known as "mitosis", during which the cell duplicates its genetic material and separates it into two identical halves, which ...
Sam Houston State study examines use of GIS in policing
2014-09-16
HUNTSVILLE, TX (9/16/14) -- Police agencies are using Geographic Information Systems (GIS) for mapping crime, identifying crime "hot spots," assigning officers, and profiling offenders, but little research has been done about the effectiveness of the technology in curbing crime, according to a study at Sam Houston State University (SHSU).
"This review provides a reality check on the current status of GIS assessment in policing and the findings are not positive," said Yan Zhang, a SHSU professor and co-author of "Geographic Information System Effects on Policing Efficacy: ...
Do you always get what you pay for? How consumers mispredict product quality
2014-09-16
Consumers are willing to spend thousands of dollars for luxury brand watches such as Rolex and Cartier because they are synonymous with high quality. But does this mean that inexpensive watches made by low-cost rivals must always be low quality? According to a new study in the Journal of Consumer Research, consumers mistakenly predict product quality based on quality consistency in other price ranges.
"Highly consistent quality in one price range is enough for consumers to assume that quality can be predicted by price. Based on this belief, consumers assume high or low ...
LAST 30 PRESS RELEASES:
Osteoporosis treatment benefits people older than 80
Consuming more protein may protect patients taking anti-obesity drug from muscle loss
Thyroid treatment may improve gut health in people with hypothyroidism
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
High blood sugar may have a negative impact on men’s sexual health
Emotional health of parents tied to well-being of children with growth hormone deficiency
Oxytocin may reduce mood changes in women with disrupted sleep
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce
Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes
New research expands laser technology
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers
Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes
CTE and normal aging are difficult to distinguish, new study finds
Molecular arms race: How the genome defends itself against internal enemies
Tiny chip speeds up antibody mapping for faster vaccine design
KTU experts reveal why cultural heritage is important for community unity
More misfolded proteins than previously known may contribute to Alzheimer’s and dementia
“Too much going on”: Autistic adults overwhelmed by non-verbal social cues
What’s driving America’s deep freezes in a warming world?
A key role of brain protein in learning and memory is deciphered by scientists
Heart attacks don’t follow a Hollywood script
Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories
Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds
Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%
Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR
New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications
[Press-News.org] Single fraction RT as effective as multiple fraction RT for bone metastasesAccording to patient-reported data